Business context and reporting period
This is Mohawk Group Holdings, Inc.’s Form 10-K for the fiscal year ended December 31, 2019, filed March 30, 2020. It reports annual results, not standalone fourth-quarter results; separate Q4 figures are not provided in the supplied filing text. The request metadata names Aterian, Inc., but the filing identifies the registrant as Mohawk Group Holdings, Inc. (Nasdaq: MWK).
Mohawk sold consumer products under brands including hOmeLabs, Vremi, Xtava and RIF6, using its AIMEE analytics and automation platform. Approximately 95% of 2019 revenue was through or with Amazon’s U.S. marketplace. The company completed its IPO in June 2019 and acquired personal-wellness product assets in September 2019.
Financial performance and liquidity
| Metric | FY 2018 | FY 2019 |
|---|---|---|
| Net revenue | $73.3 million | $114.5 million |
| Gross profit / margin | $26.0 million / 35.5% | $45.0 million / 39.4% |
| Operating loss | $(29.4) million | $(54.3) million |
| Net loss | $(31.8) million | $(58.8) million |
| Net loss per share, diluted | $(3.13) | $(4.35) |
| Cash used in operating activities | $(30.3) million | $(25.2) million |
| Adjusted EBITDA (non-GAAP) | $(28.6) million | $(19.5) million |
| Contribution margin (non-GAAP) | $(7.8) million | $2.5 million |
Revenue grew 56.2%. Direct-channel revenue rose 61.3% to $111.4 million; managed SaaS revenue increased to $1.7 million from $0.5 million, while wholesale revenue fell to $1.4 million from $3.7 million. Environmental appliances were the largest product category, generating $64.5 million. Gross margin improved as direct sales and product unit economics increased. Sales and distribution costs fell to 48.2% of revenue from 55.2%, while R&D and G&A increased substantially.
The GAAP net loss widened despite improved non-GAAP Adjusted EBITDA and contribution margin. Stock-based compensation was $34.7 million in 2019, including a substantial IPO-related expense; it is a key reason the GAAP loss increased.
At December 31, 2019, cash was $30.4 million, inventory $36.2 million, total current assets $73.0 million, and current liabilities $53.2 million. The balance sheet showed total assets of $74.4 million, total liabilities of $63.7 million and stockholders’ equity of $10.7 million. Operating cash burn was $25.2 million; investing cash use was $1.3 million and financing provided $36.6 million.
Debt was highly utilized: the MidCap revolver had approximately $23.0 million outstanding against a $25.0 million facility, with no availability reported at year-end; the Horizon term loan had $15.0 million principal outstanding. The balance sheet carries these borrowings net of financing costs at approximately $35.1 million. Both facilities are secured by company assets and include restrictive covenants and minimum-liquidity requirements, including a $5.0 million minimum. The company reported covenant compliance at year-end.
Material changes, outlook and key risks
- Growth and costs: Revenue increased 56.2%, but operating expenses rose 79.3% to $99.4 million, driven partly by higher stock compensation, R&D investment and public-company costs. The company remained loss-making and cash-flow negative.
- Going concern: Management and the auditor disclosed substantial doubt about the company’s ability to continue as a going concern. Management cited plans to grow revenue, improve gross margins and fulfillment costs, and extend vendor terms, while also considering additional financing. It warned that failure to improve results or obtain financing could require spending delays, reduced product and software investment, or a significantly smaller business.
- COVID-19: The pandemic was a subsequent event with uncertain financial impact. Nearly all products were sourced and manufactured in China; one key manufacturer, expected to supply over 30% of 2020 inventory, had reopened and reached over 90% capacity in early March 2020. The filing warned of possible supply, logistics, marketplace, demand and liquidity disruption, and potential covenant or financing pressure.
- Platform concentration: Reliance on Amazon exposes sales, fulfillment, listings, payments and customer reach to its policies and service changes. The company reported a temporary loss of Prime delivery certification in Q3 and Q4 2019 and noted Amazon’s COVID-era restrictions on certain non-essential goods.
- Regulatory and product matters: Mohawk was negotiating a penalty with the California Energy Commission over appliance listings. A DOE test notice challenged a dehumidifier model’s energy-conservation compliance; any penalty was not estimable. Certain products were also disputed under EPA ENERGY STAR testing, and affected products were not being sold or marketed pending resolution. The company’s 2018 hair-dryer recall was substantially completed; the remaining liability was $0.1 million after a $1.4 million reserve reversal in 2019.
- Controls: Management concluded disclosure controls and internal control over financial reporting were ineffective at year-end, with unremediated material weaknesses involving IT access and change management, journal-entry and reconciliation reviews, stock-compensation accounting, and accounting/disclosure review.
- Other notable items: The Aussie Health asset acquisition had $1.3 million stated consideration, plus a working-capital payment; it included a $0.2 million seller note bearing 8% interest. The company recorded $0.8 million of inventory liquidation charges and a $0.3 million accrual for governmental agency penalties in 2019. No specific financial guidance was provided.
Important facts for investors to verify
- Confirm the registrant and ticker: the filing is for Mohawk Group Holdings, Inc. (MWK), not a filing under Aterian, Inc.
- Assess the going-concern warning against current cash needs, operating cash burn, revolver availability, covenant compliance and access to additional capital.
- Verify the status and financial consequences of the CEC, DOE and EPA matters, including any penalties, product restrictions or required redesigns.
- Track Amazon concentration, Prime eligibility, marketplace policy changes and the company’s progress diversifying sales channels.
- Evaluate whether revenue growth and improved contribution margin can persist while operating losses, inventory needs and cash burn are reduced.
- Reconcile IPO proceeds: the filing gives approximately $29.4 million net proceeds in one section, while cash-flow and MD&A figures imply approximately $30.6 million after offering costs; clarify the difference.